Place of bevacizumab in radiation-induced edema and necrosis.
Kayseri Education and Research Hospital, Department of Radiation Oncology.
Yasemin
Y
Benderli Cihan
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D004487:Edema / Q000517:prevention & control*; D006801:Humans; D009336:Necrosis / Q000517:prevention & control*; D011832:Radiation Injuries / Q000517:prevention & control*; D011878:Radiotherapy / Q000009:adverse effects*
D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab